UDI: Value Beyond Compliance
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
Related Resources
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Toolkits/Methodology
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch
Advisory
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.